Southampton, PA, United States of America

Nageswara R Palepu

This inventor holds 24 USPTO granted patents and 7 published patent applications, plus 3 CIPO patents, primarily in Pharmaceutical Formulations. Top assignees: Smithkline Beecham Corporation, Erbamont Inc., Scidose, LLC. Active years: 1991-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nageswara R Palepu. Retrieved from https://idiyas.com/inventor/nageswara-r-palepu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 24 

% Patents Active = 79.2


Average Co-Inventor Count = 1.4

ph-index = 10

Forward Citations = 277(Granted Patents)


Location History:

  • Dublin, OH (US) (1991 - 1993)
  • Lansdale, PA (US) (1994 - 1998)
  • Northwood, GB (2001 - 2002)
  • Harlow, GB (2002)
  • Broomfield, CO (US) (2002)
  • Millcreek, WA (US) (2003 - 2012)
  • South Hampton, PA (US) (2009 - 2014)
  • Southampton, PA (US) (2010 - 2019)

Company Filing History:


Years Active: 1991-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Fulvestrant Formulations
Docetaxel Formulations
Lyophilization Process
Controlled Release
Pharmaceutical Infusion
Sustained Release Tablets
Bite-Dispersion Tablets
Biophosphonates Administration
Eprosartan Complexes
Amifostine Concentrate
Cyclophosphamide Lyophilizates
Argatroban Formulation
24 patents (USPTO):Explore Patents

Title: Innovations and Contributions of Nageswara R. Palepu

Introduction: Nageswara R. Palepu, based in Southampton, PA, is a prominent inventor with a remarkable portfolio of 24 patents to his name. His work primarily focuses on pharmaceutical formulations, particularly in the area of injectable medications. His innovations continue to influence the field of medical treatments.

Latest Patents: Among his significant contributions are the latest patents related to Fulvestrant formulations. These formulations are designed for intramuscular injection at concentrations exceeding 40 mg/ml, created without the use of castor oil and its derivatives. This advancement reflects the ongoing efforts to improve drug delivery methods and enhance patient care.

Career Highlights: Throughout his career, Nageswara has worked with esteemed companies such as SmithKline Beecham Corporation and Erbamont Inc. His experiences in these organizations have undoubtedly enriched his expertise and contributed to his innovative endeavors in pharmaceutical development.

Collaborations: Nageswara has collaborated with other talented individuals in the field, including Gopadi M. Venkatesh and Tomaz R. Herzyk. These partnerships highlight the importance of teamwork in the pursuit of groundbreaking inventions and advancements in technology.

Conclusion: Nageswara R. Palepu's body of work reflects significant advancements in pharmaceutical formulations and showcases his dedication to improving medicinal applications. With his continued contributions to the field, he stands as a notable figure in the realm of innovation and invention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…